You have no items in your shopping cart.
Cart summary
Item 1 of 3
Item 1 of 3
Anti-Spike RBD Reference Antibody (Cilgavimab)
Catalog Number: orb1818481
| Catalog Number | orb1818481 |
|---|---|
| Category | Antibodies |
| Description | Recombinant Antibody |
| Clonality | Monoclonal |
| Tested applications | ELISA, FC |
| Reactivity | Virus |
| Isotype | IgG1 |
| Antibody Type | Primary Antibody |
| Concentration | 1mg/ml |
| Form/Appearance | Purified monoclonal antibody supplied in PBS, pH 6.0, without preservative.This antibody is purified through a protein A column. |
| Conjugation | Unconjugated |
| MW | 148.82 |
| UniProt ID | NA |
| Protein Sequence | Spike RBD |
| Expression System | CHO Cell |
| Endotoxins | < 0.001EU/μg,determined by LAL method. |
| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles |
| Note | For research use only |
| Expiration Date | 12 months from date of receipt. |
The purity of Anti-Spike RBD Reference Antibody (Cilgavimab) is more than 99.35%, determined by SEC-HPLC.
Immobilized 2019nCoV RBD His at 2 µg/mL can bind Anti-Spike RBD Reference Antibody (Cilgavimab), EC50=0.01122 µg/mL.
Anti-Spike RBD Reference Antibody (Cilgavimab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%
